Correction to the ERS Specialty Drug List
On 10/6/2017, BCBSTX determined there were 2 HCPCS codes for Specialty Drugs that were listed incorrectly on the ERS Specialty Drug Prior Authorization List and a corrected list was posted to the Provider Website under Clinical Resources. Although the name of the drugs was correctly listed, the HCPCS codes were not. The following drugs have been corrected to reflect the correct HCPCS codes:
- REMODULIN - J3285
- CYTOSAR - J9100
We apologize for this error and any inconvenience it may have caused. If you have any questions, please contact your Network Management Representative.